Amaç Oral lökoplaki (OL), oral mukozanın en yaygın prekanseröz lezyonudur. Etiyolojide en sık sorumlu tutulan faktörler, tütün ve alkol kullanımıdır. En yaygın yerleşim bölgesi bukkal mukoza olmakla birlikte, oral mukozanın diğer bölgelerini de tutabilir. Histopatolojik olarak lezyon spektrumu, displazinin eşlik etmediği skuamöz hiperplaziden; hafif, orta ve şiddetli displaziye kadar değişkenlik gösterebilir. Malign transformasyon riskinin en önemli belirleyicisi ise; displazi varlığı ile displazi derecesidir.
Introduction
Oral leukoplakia (OL) is the most common precancerous lesion of the oral mucosa. 1 The etiology is multifactorial with chief risk factors being tobacco and alcohol usage. 2 In addition, human papillomavirus (HPV), dental restoration, mechanical irritation, candidiasis, low serum vitamin A and carotene are other etiological factors. 3 Meanwhile, the significant number of cases whose cause cannot be determined are known as idiopathic OL. 4 OL lesions can be located in any part of the mouth; however, the most common site is in the buccal mucosa. 5 The two main clinical forms of oral leukoplakia, homogenous and non-homogeneous, are differentiated by their surface characteristics and clinical lesion morphologies. Homogenous OL has two subtypes: flat-thin (thickness <200 μm) ( Fig. 1) and thick-fissured (thick-ness> 200 μm) (Fig. 2) ; while there are 3 clinical types of non-homogenous OL: granular nodular (Fig. 3) , erythroleukoplakia ( Fig. 4) and verrucous. Another important clinical type, proliferative verrucous OL (PVL) is considered a variant of verrucous OL. Rates of post-treatment recurrence and malignant transformation (verrucous carcinoma) in PVL are very high. 6 Biopsy is an essential step when faced with lesions in the oral mucosa lasting more than 2-4 weeks and suggesting leukoplakia. The biopsy specimen should be taken from areas of erythema, induration or erosion, if present. 7 Histopathological features of OL may vary from squamous hyperplasia unaccompanied by dysplasia to mild, moderate or severe dysplasia. The presence of dysplasia is considered to be the most important risk factor for malignant transformation. 8 The rate of malignant transformation is reported as 0.13-17.5% depending on geographic region and ethnic characteristics. 9 In head and neck tumors, carcinogen exposure (e.g. tobacco, alcohol) can lead to premalignant and malignant changes at molecular level in all mucosal areas. This is defined as field cancerization. For this reason, the possibility of multiple cancers in adjacent regions such as the nasopharynx, oropharynx, larynx, and lung should be considered when dealing with patients with a history of heavy alcohol/tobacco consumption or previous oral cancer diagnosis. 10 There are many treatment options for OL, both invasive and medical (topical and systemic). Invasive treatment options include conventional surgery, laser surgery (excision or evaporation), electrocoagulation and cryotherapy. 11 Table 2 . Frequency of all OLs and oral mucosa localization was given to these patients (Table 1) .
Methods

In our study, patients who applied to Ege University
A total of 87 OL lesions were noted; with 1 OL in 72 patients (91.1%) 2 OL in 6 patients (7.5%), and 3 OL in 1 patient (1.2%). However, the total of OL lesions evaluated in our study was only 79 since only histopathologically examined lesions were included and only one histopathological sampling was performed on patients with multiple lesions.
Examination of the distribution pattern showed that most lesions were located in the buccal mucosa (30 lesions: 34.4%). The second most common location with 25 (28.7%) lesions was the tongue. Following this, there were 11 lesions (12.6%) in the gingiva, 6 lesions (6.8%) in the hard palate, 7 lesions (8%) in the soft palate, 5 lesions (5.7%) in the floor of the mouth and 3 lesions (3.4%) in the labial mucosa ( Table 2) .
Homogenous OL was seen in 39 patients (49.4%) and nonhomogeneous OL in 40 patients (50.6%). Of the 39 homogeneous OLs, 28 (35.4%) were thick-fissured and 11 (13.9%) were flat-thin. Of the 40 patients with nonhomogenous OL, 18 (22.8%) had granular nodules, 9 (11.4%) had verrucous, 8 (10.1%) had erythroleukoplakia and 5 (6.3%) had proliferative verrucous OL type ( Table 3) .
Biopsies were taken from the lesions of all patients included in the study and histological evaluation was
performed. As a result of this evaluation, 37 (46.8%) cases of squamous hyperplasia (SH) and hyperkeratosis, 12 (15.1%) cases of squamous intraepithelial neoplasia 1 (SIN1), 17 (21.5%) cases of SIN2, and 9 (11.3%) cases of SIN3 carcinoma in situ (CIS) were detected. In addition, there were 3 (3.7%) cases of squamous hyperplasia + SIN1, and 1 patient (1.1%) with both SIN2 + SIN3 ( Table 4 ).
The treatment methods used for the 79 patients in the study were as follows: 38 (48.1%) underwent conventional surgical treatment, 11 (13.9%) had medical treatment and cryotherapy was used for 7 (8.9%). Smoking cessation was employed in 5 (6.3%) patients, amalgam exchange in 5 (6.3%), oral hygiene in 3 (3.8%) patients and 'watch and wait' method in 3 (3.8%). In 7 patients (9.2%), multiple methods were administered concurrently ( (Table 6 ).
Discussion
Oral leukoplakia was defined by Van der Waal et al.,
as a predominantly white lesion or plaque with suspicious behavior that can be diagnosed after clinical and histopathological exclusion of other identifiable white diseases and disorders. 12 Although OL was originally thought to be more prevalent in men because of tobacco consumption, in recent years, the disparity between OL rates in men and women has diminished. 5 In their study, Starzynska et al., screened 55911 patients from between 1999 and 2009, finding 204 OL patients for epidemiological and clinical analysis; they ascertained a male population of 49% (n=100) and female population of 51% (n=104). 13 In another study carried out by Liu et al., of 218 patients, 50.5% (n=110) patients were male and 49.5% (n=108) were female. 14 76% (n=24) were female. In the same study, the frequency of chronic mechanical trauma such as from amalgam fillings was 28.93% (n=59). 13 As in the literature, we agree that mechanical trauma caused by amalgam fillings may be a risk factor. In our patient group, the presence of amalgam fillings was as high as 28 patients (35.4%).
It is detable whether Candida albicans is a risk factor for OL, or simply a superinfection over a pre-existing lesion. 17 Considering that some types of candida may cause nonhomogenous OL-like lesions, it is argued that lesions that do not respond to antifungal therapy should be considered as oral leukoplakia and should be approached accordingly. 18 The Candida species of fungal infections, especially Candida albicans, often accompany OL lesions. 19 In their study evaluating the relationship between candida colonization and OL, Sarkar et al. compared 40 OL patients with 21 control patients. On direct examination, Candida albicans was found in 47.5% of OL patients but only 14.3% of the control group. In the subsequent mycological culture, 64.9% of non-homogenous OL patients and 45% of all OL patients were positive for Candida albicans and the results were statistically significant. 20 In our study, mycological examination was performed on 22 patients (27.9%) and Candida albicans was detected in 15 (19%). Of these, 11 (13.9%) were female and 4 (5%) were male.
In a study evaluating the location of lesions in 1046 OL patients, Lee and colleagues obtained similar results to our study. Their distribution comprised lesions in the buccal mucosa in 660 patients (63%), on the tongue in 253 (24.1%), in the gingiva in 53 (5%), in the labial mucosa in 40 (3.8%), on the soft palate in 22 (2.1%), on the hard palate in 10 (0.95%) and at the floor of the mouth in 8 patients (0.76%). 16 Additionally, in the study of Chandran, of the 95 patients, 18.9% (n=18) of the OL lesions were located in the buccal mucosa, 17.9% (n=17) in the gingival, 26.3% (n=25) in the floor of the mouth, 18.9% (n=18) on the tongue, 7.5% (n=6) in the soft palate, 3.2% (n=3) in the hard palate and 4.3% (n=4) settled in the labial mucosa. 21 Similar to the literature, the most common location in our study was the buccal mucosa.
The location and number of lesions in leukoplakia are significant for close follow-up because of the higher risk of malignancy in certain localizations, such as the tongue and floor of the mouth. In our study, we found a single lesion in 72 patients (91.1%), 2 lesions (7.5%) in 6 patients and 3 (1.2%) in 1 patient, making a total of 87 lesions. The most common site was buccal mucosa with a rate of 31.6% (n=25). The tongue area was second with 29.1% (n=23). Subsequent frequencies were 11.4% (n=9) in the gingiva, 7.6% (n=6) in the hard palate, 6.3% (n=5) in the soft palate, 6.3% (n=5) in the floor of the mouth and 2.5% (n=2) in labial mucosa.
Non-homogenous leukoplakias are known to carry more risk than homogenous leukoplakia. In the literature, Chandran In our study, 38 patients (48.1%) received conventional surgical treatment, 11 (13.9%) had medical treatment, 7 (8.9%) had cryotherapy; smoking was stopped in 5 patients (8%), amalgams were changed in 5 (6.3%), oral hygiene was improved in 3 (3.8%) and 'watch and wait' method was applied in 3 cases (3.8%). In 7 patients (9.2%), multiple options were administered concurrently. In 2 (2.6%) of these patients, smoking cessation and oral hygiene with provided, while 2 (2.6%) underwent smoking cessation and medical treatment, 1(1.3%) had cryotherapy as well as cessation of smoking, 1 patient (1.3%) underwent smoking cessation, amalgam replacement and oral hygiene and in 1 case (1.3%) amalgam exchange, oral hygiene change and medical treatment were applied. In our study, as in the literature, surgical treatment is preferred in lesions with high risk of malignant transformation such as non-homogenous OL.
Although there are many treatment options for oral leukoplakia, there are no randomized controlled studies on treatment efficacy. The lack of standardization of treatment methods is also an important problem. Over a one-year period, the rate of malignant transformation for untreated OL lesions is 2-3%. This risk is higher for erythroleukoplakia, erythroplakia and proliferative verrucous leukoplakia. Clearly, the main target in all treatment options is to reduce this rate, but even when current surgical approaches are applied, if risk factors persist, then the likelihood of leukoplakia developing in other regions due to field cancerization remains. 13 In our study, 6 patients (7.5%) with leukoplakia had additional field cancerization. 1 (1.2%) of these patients had smoking and alcohol habits, and 1 (1.2%) had habits of cigarette smoking, alcohol consumption and tobacco chewing, while 4 patients (5.2%) had no known risk factors. 4 (5.2%) of the 6 patients (7,8%) with field cancerization had tongue carcinoma, 1 (1.2%) had lung carcinoma, while 1 (1.2%) had tonsil and larynx CIS, hypopharynx and epiglottis SHK. In our study, no significant statistical relationship was found between field cancerization and risk factors such as localization, clinical type or the histopathological features of OL. However, we would like to emphasize that the presence of leukoplakia may be a significant finding in terms of field cancerization.
In conclusion, to minimize the risk of malignant transformation in leukoplakia lesions, the elimination of risk factors and early biopsy are essential. In patients whose histopathological examination reveals dysplasia or malignancy, regular follow-up and a multidisciplinary approach related to field cancerization are of vital importance in patients with oral leukoplakia.
